{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T03:50:17Z","timestamp":1788839417866,"version":"build-2803163510"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101396","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:05:24Z","timestamp":1777590324000},"page":"101396","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT)"],"prefix":"10.1016","volume":"77","author":[{"given":"Chiara","family":"Oltolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Piekarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Signori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Robin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Neofytos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Reigadas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Chemaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas H.","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Munoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin W.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Mikulska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"18","key":"10.1016\/j.blre.2026.101396_bb0005","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJMoa1801550","article-title":"Changes in prevalence of health care associated infections in U.S. hospitals","volume":"379","author":"Magill","year":"2018","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0010","doi-asserted-by":"crossref","first-page":"152","DOI":"10.7326\/M16-2733","article-title":"Increasing incidence of multiply recurrent Clostridium difficile infection in the United States","volume":"167","author":"Ma","year":"2017","journal-title":"Ann Intern Med"},{"issue":"14","key":"10.1016\/j.blre.2026.101396_bb0015","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1056\/NEJMoa1910215","article-title":"Trends in U.S. burden of Clostridioides difficile infection and outcomes","volume":"382","author":"Guh","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101396_bb0020","author":"European Centre for Disease Prevention and Control"},{"issue":"10","key":"10.1016\/j.blre.2026.101396_bb0025","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1016\/j.jamda.2022.01.075","article-title":"Mortality, health care use, and costs of Clostridioides difficile infections in older adults","volume":"23","author":"Feuerstadt","year":"2022","journal-title":"J Am Med Dir Assoc"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0030","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1017\/ice.2017.12","article-title":"Evaluating risk factors for Clostridium difficile infection in stem cell transplant recipients: a national study","volume":"38","author":"Shah","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"10","key":"10.1016\/j.blre.2026.101396_bb0035","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1016\/j.bbmt.2014.06.001","article-title":"Clostridium difficile infection in the hematopoietic unit: a meta-analysis of published studies","volume":"20","author":"Zacharioudakis","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101396_bb0040","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.801475","article-title":"Prevalence of Clostridium difficile infection in the hematopoietic transplantation setting: update of systematic review and meta-analysis","volume":"12","author":"Luo","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.blre.2026.101396_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103371","article-title":"Management of Clostridioides difficile infection in patients with haematological malignancies and after cellular therapy: guidelines from 10th European conference on infections in Leukaemia (ECIL-10)","volume":"87","author":"Mikulska","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.blre.2026.101396_bb0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0055","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1128\/CMR.00016-13","article-title":"Diagnosis of Clostridium difficile infection: an ongoing conundrum for clinicians and for clinical laboratories","volume":"26","author":"Burnham","year":"2013","journal-title":"Clin Microbiol Rev"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0060","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1086\/651706","article-title":"Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA)","volume":"31","author":"Cohen","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1099\/jmm.0.000028","article-title":"Risk factors, outcomes and epidemiology associated with Clostridium difficile infection in patients with hematological malignancy in a tertiary care hospital in China","volume":"64","author":"Gu","year":"2015","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.blre.2026.101396_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2020.01618","article-title":"High prevalence of genetically-related Clostridium difficile strains at a single Hemato-oncology ward over 10 years","volume":"11","author":"Waker","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.blre.2026.101396_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1668584","article-title":"Multi-drug resistant Clostridioides difficile isolate ST81 is prominent in hematological patients in a teaching hospital in China","volume":"15","author":"Zhao","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.blre.2026.101396_bb0080","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.anaerobe.2013.10.001","article-title":"The impact of cefepime as first line therapy for neutropenic fever on Clostridium difficile rates among hematology and oncology patients","volume":"24","author":"Muldoon","year":"2013","journal-title":"Anaerobe"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0085","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1186\/s13104-020-05085-3","article-title":"Impact of an antimicrobial stewardship program in the antimicrobial-resistant and prevalence of clostridioides difficile infection and amount of antimicrobial consumed in cancer patients","volume":"13","author":"Mardani","year":"2020","journal-title":"BMC Res Notes"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0090","doi-asserted-by":"crossref","first-page":"94.e1","DOI":"10.1016\/j.bbmt.2020.10.005","article-title":"Impact of a Clostridioides difficile testing computerized clinical decision support tool on an adult stem cell transplantation and hematologic malignancies unit","volume":"27","author":"Nix","year":"2021","journal-title":"Transplant Cell Ther"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0095","first-page":"1","article-title":"Multiplexed gastrointestinal PCR panels for the evaluation of diarrhea in patients with acute leukemia","volume":"46","author":"Ford","year":"2024","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"12","key":"10.1016\/j.blre.2026.101396_bb0100","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.cmi.2025.08.013","article-title":"Impact of enhanced infection control and antimicrobial stewardship on infections by Clostridioides difficile, vancomycin-resistant enterococci, and third-generation cephalosporin-resistant Enterobacterales: a stepped-wedge cluster intervention study","volume":"31","author":"Classen","year":"2025","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0105","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/jgid.jgid_192_23","article-title":"Improved clinical outcomes with appropriate Meropenem De-escalation in patients with febrile neutropenia","volume":"16","author":"Luu","year":"2024","journal-title":"J Glob Infect"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0110","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1177\/1078155221998735","article-title":"Evaluating Clostridioides difficile infection (CDI) treatment duration in hematology\/oncology patients receiving concurrent non-CDI antibiotics","volume":"28","author":"Keats","year":"2022","journal-title":"J Oncol Pharm Pract"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0115","article-title":"Clinical characteristics and outcomes of Clostridioides difficile infection in cancer patients from a tertiary care hospital","volume":"17","author":"Arslan","year":"2025","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0120","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00277-009-0772-0","article-title":"Clostridium difficile-associated diarrhoea, a frequent complication in patients with acute myeloid leukaemia","volume":"89","author":"Schalk","year":"2010","journal-title":"Ann Hematol"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0125","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ejon.2010.11.002","article-title":"Infection probability score: a predictor of Clostridium difficile-associated disease onset in patients with haematological malignancy","volume":"15","author":"Apostolopoulou","year":"2011","journal-title":"Eur J Oncol Nurs"},{"issue":"8","key":"10.1016\/j.blre.2026.101396_bb0130","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.3109\/10428194.2012.654472","article-title":"Risk factors associated with Clostridioides difficile infection in adult oncology patients with a history of recent hospitalization for febrile neutropenia","volume":"53","author":"Bishop","year":"2012","journal-title":"Leuk Lymphoma"},{"issue":"2","key":"10.1016\/j.blre.2026.101396_bb0135","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1086\/669081","article-title":"Clostridium difficile infection and limitations of markers for severity in patients with hematologic malignancy","volume":"34","author":"Wang","year":"2013","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"21","key":"10.1016\/j.blre.2026.101396_bb0140","doi-asserted-by":"crossref","first-page":"6602","DOI":"10.3748\/wjg.v20.i21.6602","article-title":"Hematologic diseases: high risk of Clostridium difficile associated diarrhea","volume":"20","author":"Gweon","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1177\/1078155213490004","article-title":"A retrospective review of metronidazole and vancomycin in the management of Clostridium difficile infection in patients with hematologic malignancies","volume":"20","author":"Parmar","year":"2014","journal-title":"J Oncol Pharm Pract"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0150","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1590\/S0036-46652014000400010","article-title":"Incidence of diarrhea by Clostridium difficile in hematologic patients and hematopoietic stem cell transplantation patients: risk factors for severe forms and death","volume":"56","author":"Spadao","year":"2014","journal-title":"Rev Inst Med Trop Sao Paulo"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0155","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.bbmt.2014.02.022","article-title":"Clostridium difficile infection in patients with acute myelogenous leukemia and in patients undergoing allogeneic stem cell transplantation: epidemiology and risk factor analysis","volume":"20","author":"Vehreschild","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.blre.2026.101396_bb0160","first-page":"2039","article-title":"Predictors of mortality attributable to Clostridium difficile infection in patients with underlying malignancy","volume":"22","author":"Yoon","year":"2014","journal-title":"Support Care Cancer"},{"issue":"7","key":"10.1016\/j.blre.2026.101396_bb0165","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1017\/ice.2015.54","article-title":"Outcomes of Clostridium difficile infection in hospitalized leukemia patients: a nationwide analysis","volume":"36","author":"Luo","year":"2015","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157839","article-title":"Clostridium difficile infections amongst patients with haematological malignancies: a data linkage study","volume":"11","author":"Selvey","year":"2016","journal-title":"PloS One"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0175","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1017\/ice.2017.48","article-title":"Risk of Clostridium difficile infection in hematology-oncology patients colonized with toxigenic C. difficile","volume":"38","author":"Cannon","year":"2017","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"8","key":"10.1016\/j.blre.2026.101396_bb0180","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1016\/j.medmal.2017.07.002","article-title":"Treating Clostridium difficile infection in patients presenting with hematological malignancies: are current guidelines applicable?","volume":"47","author":"Robin","year":"2017","journal-title":"Med Mal Infect"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0185","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1093\/jac\/dkx005","article-title":"Risk factors and impact of Clostridium difficile recurrence on haematology patients","volume":"72","author":"Scappaticci","year":"2017","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0190","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5306\/wjco.v8.i5.398","article-title":"Characteristics of Clostridium difficile infection in patients hospitalized with myelodysplastic syndrome or acute myelogenous leukemia","volume":"8","author":"Shah","year":"2017","journal-title":"World J Clin Oncol"},{"issue":"10","key":"10.1016\/j.blre.2026.101396_bb0195","doi-asserted-by":"crossref","first-page":"628","DOI":"10.14423\/SMJ.0000000000000872","article-title":"Risk, outcomes, and predictors of Clostridium difficile infection in lymphoma: a nationwide study","volume":"111","author":"Bhandari","year":"2018","journal-title":"South Med J"},{"issue":"11","key":"10.1016\/j.blre.2026.101396_bb0200","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1007\/s10096-018-3341-4","article-title":"Prognosis of Clostridium difficile infection in adult oncohaematological patients: experience from a large prospective observational study","volume":"37","author":"Larrainzar-Coghen","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"7","key":"10.1016\/j.blre.2026.101396_bb0205","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/ice.2018.83","article-title":"Clinical characteristics and outcomes of hematologic malignancy patients with positive Clostridium difficile toxin immunoassay versus polymerase chain reaction test results","volume":"39","author":"Ziegler","year":"2018","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0210","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ajic.2018.09.027","article-title":"Clostridioides difficile colonization and infection in patients with newly diagnosed acute leukemia: incidence, risk factors, and patient outcomes","volume":"47","author":"Ford","year":"2019","journal-title":"Am J Infect Control"},{"issue":"2","key":"10.1016\/j.blre.2026.101396_bb0215","doi-asserted-by":"crossref","first-page":"120","DOI":"10.5045\/br.2019.54.2.120","article-title":"Determining the risk factors associated with the development of Clostridium difficile infection in patients with hematological diseases","volume":"54","author":"Lee-Tsai","year":"2019","journal-title":"Blood Res"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0220","article-title":"Risk, outcomes, and trends of Clostridium difficile infection in multiple myeloma patients from a nationwide analysis","volume":"11","author":"Ran-Castillo","year":"2019","journal-title":"Cureus"},{"issue":"9","key":"10.1016\/j.blre.2026.101396_bb0225","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1097\/MCG.0000000000001171","article-title":"Trends in incidence and outcomes of Clostridium difficile colitis in hospitalized patients of febrile neutropenia: a nationwide analysis","volume":"53","author":"Siddiqui","year":"2019","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0230","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/1078155217740945","article-title":"Clostridium difficile treatment in neutropenic patients: clinical outcomes of metronidazole, vancomycin, combinations, and switch therapy","volume":"25","author":"Tieu","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"10.1016\/j.blre.2026.101396_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ijid.2019.10.028","article-title":"Clostridioides difficile infection in immunocompromised hospitalized patients is associated with a high recurrence rate","volume":"90","author":"Avni","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"11","key":"10.1016\/j.blre.2026.101396_bb0240","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1007\/s00277-020-04274-1","article-title":"Use of carbapenems and glycopeptides increases risk for Clostridioides difficile infections in acute myeloid leukemia patients undergoing intensive induction chemotherapy","volume":"99","author":"Ballo","year":"2020","journal-title":"Ann Hematol"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0245","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jhin.2019.12.017","article-title":"Excess burden associated with Clostridioides difficile infection in haematological patients occurring during hospitalization with induction chemotherapy in the USA","volume":"104","author":"Duhalde","year":"2020","journal-title":"J Hosp Infect"},{"issue":"7","key":"10.1016\/j.blre.2026.101396_bb0250","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1017\/ice.2020.153","article-title":"The economic burden of Clostridioides difficile infection in patients with hematological malignancies in the United States: a case-control study","volume":"41","author":"Duhalde","year":"2020","journal-title":"Infect Control Hosp Epidemiol"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0255","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jmii.2021.02.002","article-title":"Clostridioides difficile infection in patients with hematological malignancy: a multicenter study in Taiwan","volume":"54","author":"Hung","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"issue":"e1","key":"10.1016\/j.blre.2026.101396_bb0260","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1136\/ejhpharm-2020-002574","article-title":"Outcomes of Clostridioides difficile infection in adult cancer and non-cancer patients hospitalised in a tertiary hospital: a prospective cohort study","volume":"29","author":"Milenkovic","year":"2022","journal-title":"Eur J Hosp Pharm"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0265","first-page":"187","article-title":"Performance of Clostridioides difficile infection severity scores and risk factors related to 30-day all-cause mortality in patients with cancer","volume":"31","author":"De-la-Rosa-Martinez","year":"2023","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.blre.2026.101396_bb0270","doi-asserted-by":"crossref","first-page":"681","DOI":"10.36518\/2689-0216.1748","article-title":"Investigating the effects of nosocomial Clostridioides difficile infection among acute leukemia patients: insights from the 2020 National Inpatient Sample","volume":"5","author":"Bodla","year":"2024","journal-title":"HCA Healthc J Med"},{"issue":"10","key":"10.1016\/j.blre.2026.101396_bb0275","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.14149","article-title":"Epidemiologic trends in Clostridioides difficile infections in a regional community hospital network","volume":"2","author":"Turner","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"26","key":"10.1016\/j.blre.2026.101396_bb0280","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.26.2100704","article-title":"A point-prevalence study on community and inpatient Clostridioides difficile infections (CDI): results from combatting bacterial resistance in Europe CDI (COMBACTE-CDI), July to November 2018","volume":"27","author":"Viprey","year":"2022","journal-title":"Euro Surveill"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0285","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S2213-2600(24)00257-1","article-title":"Empirical antibiotic therapy for sepsis: save the anaerobic microbiota","volume":"13","author":"Kullberg","year":"2025","journal-title":"Lancet Respir Med"},{"issue":"7","key":"10.1016\/j.blre.2026.101396_bb0290","doi-asserted-by":"crossref","first-page":"471.e1","DOI":"10.1016\/j.jtct.2023.04.010","article-title":"An algorithm addressing the problem of overdiagnosis of Clostridioides difficile infections in hematopoietic stem cell transplantation recipients: effects on C. Difficile infection rates and patient outcomes","volume":"29","author":"Ford","year":"2023","journal-title":"Transplant Cell Ther"},{"issue":"3","key":"10.1016\/j.blre.2026.101396_bb0295","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ajic.2023.11.022","article-title":"Analysis of health care facility-onset Clostridioides difficile infection (CDI) in a hematopoietic cell transplant (HCT) unit: a call for diagnostic stewardship in a complex patient population","volume":"52","author":"Swetky","year":"2024","journal-title":"Am J Infect Control"},{"issue":"13","key":"10.1016\/j.blre.2026.101396_bb0300","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1080\/10428194.2020.1805109","article-title":"Updated safety of midostaurin plus chemotherapy in newly diagnosed FLT3 mutation-positive acute myeloid leukemia: the RADIUS-X expanded access program","volume":"61","author":"Roboz","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.blre.2026.101396_bb0305","doi-asserted-by":"crossref","DOI":"10.1177\/20420986241308089","article-title":"Unveiling unexpected adverse events: post-marketing safety surveillance of gilteritinib and midostaurin from the FDA adverse event reporting database","volume":"16","author":"Jiang","year":"2025","journal-title":"Ther Adv Drug Saf"},{"issue":"7","key":"10.1016\/j.blre.2026.101396_bb0310","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJMoa2012971","article-title":"Azacitidine and venetoclax in previously untreated acute myeloid leukemia","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0315","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","article-title":"Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.blre.2026.101396_bb0320","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1182\/blood.2020004856","article-title":"Venetoclax plus LDAC for newly diagnosed AML ineligible for intensive chemotherapy: a phase 3 randomized placebo-controlled trial","volume":"135","author":"Wei","year":"2020","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0325","doi-asserted-by":"crossref","DOI":"10.1080\/16078454.2024.2343604","article-title":"Efficacy and safety of venetoclax-based combination therapy for previously untreated acute myeloid leukemia: a meta-analysis","volume":"29","author":"He","year":"2024","journal-title":"Hematology"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0330","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1158\/2643-3230.BCD-21-0028","article-title":"Bispecific antibodies in multiple myeloma: present and future","volume":"2","author":"Lancman","year":"2021","journal-title":"Blood Cancer Discov"},{"issue":"12","key":"10.1016\/j.blre.2026.101396_bb0335","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1093\/cid\/ciab826","article-title":"Ultrasensitive and quantitative toxin measurement correlates with baseline severity, severe outcomes, and recurrence among hospitalized patients with Clostridioides difficile infection","volume":"74","author":"Alonso","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.blre.2026.101396_bb0340","doi-asserted-by":"crossref","first-page":"e460","DOI":"10.1093\/cid\/ciaa1184","article-title":"Clostridioides difficile infection in cancer and immunocompromised patients: relevance of a two-step diagnostic algorithm and infecting ribotypes on clinical outcomes","volume":"72","author":"Yepez Guevara","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2026.101396_bb0345","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.anaerobe.2016.04.001","article-title":"Neutrophil-mediated inflammation in the pathogenesis of Clostridium difficile infections","volume":"41","author":"Shinsmon","year":"2016","journal-title":"Anaerobe"},{"key":"10.1016\/j.blre.2026.101396_bb0350","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1186\/s12879-024-09364-3","article-title":"Clostridioides difficile infection, recurrence and the associated healthcare consumption in Sweden between 2006 and 2019: a population-based cohort study","volume":"24","author":"Boven","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.blre.2026.101396_bb0355","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1056\/NEJMoa0910812","article-title":"Fidaxomicin versus vancomycin for Clostridium difficile infection","volume":"364","author":"Louie","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101396_bb0360","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1473-3099(11)70374-7","article-title":"Fidaxomicin versus vancomycin for infection with Clostridium difficile in Europe, Canada, and the USA: a double-blind, non-inferiority, randomised controlled trial","volume":"12","author":"Cornely","year":"2012","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0365","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/cid\/cir404","article-title":"Efficacy of Fidaxomicin versus vancomycin as therapy for Clostridium difficile infection in individuals taking concomitant antibiotics for other concurrent infections","volume":"53","author":"Mullane","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.blre.2026.101396_bb0370","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2012.45.5899","article-title":"Resolution of Clostridium difficile\u2013associated diarrhea in patients with cancer treated with Fidaxomicin or vancomycin","volume":"31","author":"Cornely","year":"2013","journal-title":"J Clin Oncol"},{"issue":"S2","key":"10.1016\/j.blre.2026.101396_bb0375","doi-asserted-by":"crossref","first-page":"S154","DOI":"10.1093\/cid\/cis462","article-title":"Treatment of first recurrence of Clostridium difficile infection: Fidaxomicin versus vancomycin","volume":"55","author":"Cornely","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.blre.2026.101396_bb0380","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1473-3099(17)30751-X","article-title":"Extended-pulsed fidaxomicin versus vancomycin for Clostridium difficile infection in patients 60 years and older (EXTEND): a randomised, controlled, open-label, phase 3b\/4 trial","volume":"18","author":"Guery","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.blre.2026.101396_bb0385","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1093\/cid\/ciad523","article-title":"Clinical outcomes and management of NAAT-positive\/toxin-negative Clostridioides difficile infection: a systematic review and meta-analysis","volume":"78","author":"Prosty","year":"2024","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.blre.2026.101396_bb0390","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa1602615","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection","volume":"376","author":"Wilcox","year":"2017","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.blre.2026.101396_bb0395","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/cid\/ciy171","article-title":"Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence","volume":"67","author":"Gerding","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.blre.2026.101396_bb0400","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.mayocp.2017.08.016","article-title":"Safety and efficacy of fecal microbiota transplant for recurrent Clostridium difficile infection in patients with Cancer treated with cytotoxic chemotherapy: a single-institution retrospective case series","volume":"92","author":"Hefazi","year":"2017","journal-title":"Mayo Clin Proc"},{"issue":"2","key":"10.1016\/j.blre.2026.101396_bb0405","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5005\/jp-journals-10071-24607","article-title":"Fecal microbiota transplantation for Clostridium difficile-associated diarrhea in hematopoietic stem cell transplant recipients: a single-center experience from a tertiary center in India","volume":"28","author":"Prayag","year":"2024","journal-title":"Indian J Crit Care Med"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0410","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/cid\/cir246","article-title":"The impact of ICD-9-CM code rank order on the estimated prevalence of Clostridium difficile infections","volume":"53","author":"Dubberke","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0415","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad622","article-title":"Comparative effectiveness of Fidaxomicin vs vancomycin in populations with immunocompromising conditions for the treatment of Clostridioides difficile infection: a single-center study","volume":"11","author":"Alsoubani","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.blre.2026.101396_bb0420","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1038\/s41598-024-56336-3","article-title":"Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the polish adult leukemia group","volume":"14","author":"Piekarska","year":"2024","journal-title":"Sci Rep"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:08:25Z","timestamp":1787951305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":84,"alternative-id":["S0268960X26000354"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101396","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clostridioides difficile infection in non-transplanted adults with haematological malignancy: Systematic review and meta-analysis on behalf of European Conference on Infections in Leukemia (ECIL) and Infectious Diseases Working Party (IDWP) of the European Society for Blood and Marrow Transplantation (EBMT)","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101396","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101396"}}